Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
FDA Office of Orphan Products Development University of Washington |
---|---|
Information provided by: | FDA Office of Orphan Products Development |
ClinicalTrials.gov Identifier: | NCT00004443 |
OBJECTIVES: I. Assess the safety and efficacy of NTBC in children with tyrosinemia I.
II. Evaluate the effects of NTBC on survival, rate of neurologic crises, improvement in renal tubular damage, reduction in the need for liver transplantation, and reduction in the development of hepatocarcinoma in these patients.
Condition | Intervention |
---|---|
Tyrosinemia I |
Drug: NTBC |
Study Type: | Interventional |
Study Design: | Treatment, Safety/Efficacy Study |
Estimated Enrollment: | 20 |
Study Start Date: | October 1998 |
PROTOCOL OUTLINE: Patients are stratified according to age at onset of symptoms (0-2 months vs 2-6 months vs greater than 6 months).
Patients receive oral NTBC twice a day. Treatment continues in the absence of unacceptable toxicity.
Patients are followed once a month for 6 months, then every 3 months thereafter.
Ages Eligible for Study: | up to 17 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
United States, Oregon | |
Oregon Health Sciences University | Recruiting |
Portland, Oregon, United States, 97201-3098 | |
Contact: Markus Grompe 503-494-6888 | |
United States, Washington | |
University of Washington School of Medicine | Recruiting |
Seattle, Washington, United States, 98195 | |
Contact: C. Ronald Scott 206-543-3370 | |
Canada, Quebec | |
Hopital Sainte Justine | Recruiting |
Montreal, Quebec, Canada, H3T 1C5 | |
Contact: Grant Mitchell 514-345-4931 |
Study Chair: | C. Ronald Scott | University of Washington |
Study ID Numbers: | 199/13443, UWASH-FDR001445 |
Study First Received: | October 18, 1999 |
Last Updated: | June 23, 2005 |
ClinicalTrials.gov Identifier: | NCT00004443 |
Health Authority: | United States: Federal Government |
inborn errors of metabolism rare disease tyrosinemia I |
Keratosis palmoplantaris with corneal dystrophy Tyrosinemias Metabolic Diseases Oculocutaneous tyrosinemia Amino Acid Metabolism, Inborn Errors Tyrosinemia Rare Diseases Central Nervous System Diseases |
Brain Diseases Metabolism, Inborn Errors Inborn amino acid metabolism disorder Genetic Diseases, Inborn Brain Diseases, Metabolic, Inborn Metabolic disorder Brain Diseases, Metabolic |
Nervous System Diseases |